Seventh Annual Immuno-Oncology 360°

Samik Upadhaya, PhD, research analyst, is speaking on the “Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies” virtual panel session on February 25 at 2:45 PM ET.

IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

The 7th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

Access to KOLs driving the science
Partnership opportunities with all stakeholders in Immuno-Oncology
Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology

2021 Key Topic Areas

• Discovery/Preclinical Science
• Cell & Gene Therapy
• Translational Science
• Bispecifics
• Clinical Developments
• Neoadjuvant/Adjuvant Data
• Emerging Biomarkers
• Vaccines
• Clinical Operations
• AI & Machine Learning
• Imaging Advancements
• Business Developments